Executive - Finance & Accounts (Int. Audit)

Job Description:

Intas Pharmaceuticals is seeking an Executive – Finance & Accounts (Internal Audit) to join their dynamic team and support internal audit functions across financial, operational, and compliance areas. The offers exposure to risk assessment, audit analytics, and process improvement within a fast-paced global environment.

Roles & Responsibilities:

• Assist in conducting internal audits across financial, operational, and compliance areas
• Analyze data and support audit findings using basic analytics tools
• Prepare audit reports and document observations with clarity
• entify risks, control gaps, and recommend process improvements
• Coordinate with cross-functional teams for audit execution and follow-ups
• Ensure adherence to internal policies, procedures, and regulatory requirements
• Support audit planning, documentation, and reporting activities
• Work effectively in a dynamic environment with flexibility for timelines and travel

Intas Pharmaceuticals Ltd. is a leading vertically integrated global pharmaceutical company engaged in formulation development, manufacturing, and marketing. The company is committed to addressing unmet medical and societal needs through a strong and comprehensive pharmaceutical value chain.

It operates globally through its subsidiaries under the brand
Accord Healthcare, enabling a strong presence in international markets.

Global Presence & Growth

• Present in 85+ countries worldwide
• Strong presence in North America, Europe, Latin America, Asia-Pacific, CIS & MENA regions
• Over 70% revenue from global markets
• Achieved ~19% CAGR growth
• Crossed $2.5 billion revenue milestone
• Ranked 6th in the Indian pharmaceutical market
• Among the top 10 generic players in regulated markets like the EU, US & UK

Infrastructure & Workforce

• 17 advanced facilities (manufacturing, R&D, distribution)
  • 10 in India
  • Others in the UK, Mexico & Greece
• Facilities approved by global regulators such as:
  • USFDA, EMA, MHRA, TGA, etc.
• Strong workforce of 23,000+ employees

Research & Development (R&D)

• Invests 6–7% of revenue in R&D
• 10,000+ product registrations worldwide
• Pipeline of 300+ high-value products including:
  • Biosimilars
  • New Drug Delivery Systems (NDDS)
  • First-to-File / First-to-Market products

Key Therapeutic Areas

• CNS (Central Nervous System)
• Cardiology
• Diabetology
• Gastroenterology
• Urology
• Oncology
• Animal Health

Specialized Capabilities

• Advanced Biopharma division focused on “Biosimilars for Billions”
• Expertise in niche therapies:
  • Oncology
  • Auto-immune diseases
  • Ophthalmology
  • Nephrology
  • Rheumatology
  • Hormone therapies
• Plasma Fractionation Unit for plasma-derived therapeutics with WHO-GMP certification

Quality & Compliance

• Manufacturing facilities approved by major global regulatory agencies
• Adherence to highest international quality standards
• Strong in-house development and quality control systems

Core Values

• Innovation – Driving continuous improvement
• Quality – Maintaining global standards
• Added Value – Delivering beyond expectations
• Growth – Continuous progress and expansion
• Commitment – Dedication to excellence
• Customer Delight & Collaboration
• Performance Focus & Care for Society

People & Culture

• Focus on attracting and retaining top talent
• Emphasis on diversity and global workforce
• Commitment to empowering employees and fostering growth